Derby-based company SureScreen Diagnostics is soon to provide two million of the lateral flow tests.
The Government has ordered two million of the first British-manufactured rapid lateral flow antigen tests for COVID-19 to be validated by Public Health England, for use in asymptomatic testing, Health and Social Care Secretary Matt Hancock has just announced.
SureScreen Diagnostics is to provide two million of the lateral flow tests, which provide results in under 30 minutes, by next Friday (15 January), with the potential to provide millions more in the coming months.
“Roughly one in three people with Covid-19 don’t display symptoms, meaning you can infect others unknowingly,” Matt Hancock said. “This is why asymptomatic testing is so crucial in our fight against the virus, and why I’m so grateful to see the British diagnostics industry use their ingenuity and expertise in our shared purpose to protect our communities.”
Under the Government’s Winter Plan, NHS Test and Trace is already deploying hundreds of thousands of rapid tests to identify asymptomatic cases in care homes, across the NHS, in critical infrastructure workplaces and food manufacturers, and in partnership with local Directors of Public Health.
In addition to this, the Government’s Community Testing Programme is providing asymptomatic testing through local authorities across the UK. The SureScreen tests will form part of this important asymptomatic testing activity.
David Campbell, Director of SureScreen, believes his company’s rapid antigen tests can really help in screening people both in the community and in clinical settings. Routine testing is crucial to help business and schools as well as hospitals and GPs. The company will work with DHSC on this project after its tests have been recognised by the Government and its scientists.